Table of Contents Table of Contents
Previous Page  133 / 398 Next Page
Information
Show Menu
Previous Page 133 / 398 Next Page
Page Background

128

Conclusion:

Our results offer a preclinical proof-of-concept

supporting a role for RET signalling inhibition in a targeted ther-

apeutic approach to improve the efficacy of EGFR inhibition in

OSCC.

http://dx.doi.org/10.1016/j.ijom.2017.02.445

Surgical determinants in the outcome of oral squamous cell

carcinoma

T. Liu

∗

, M. Batstone, O. Ellis

The Royal Brisbane and Women’s Hospital, Brisbane, Australia

Background:

In our recent study, we demonstrated the associa-

tion between high-volume surgeons and larger surgical margins

. 1

However, the translation of close margins to clinical outcomes

remains to be an area of controversy in the current literature.

Objectives:

To identify the surgical determinants that can improve

the treatment of patients with oral squamous cell carcinoma

(SCC).

Methods:

All oral SCC patients treated at our institution between

2008 and 2013 with a minimum of two-year follow-up were

included, while patients with contraindications for surgical man-

agement were excluded. Aheterogeneous set of predictor variables

was collected, including patient factors, surgeon factors and

tumour factors. The outcomes of interest were disease-free sur-

vival (DFS) and disease-specific survival (DSS).

Findings:

307 patients were recruited. The mean DFS and DSS

were 74.1% and 81.3%, respectively. Close and involved surgi-

cal margins were significantly correlated with surgeons who have

operated 40 cases or less during the study period (

P

= 0.0465).

On multivariate analysis, independent predictors for recurrences

were poor tumour cell differentiation (

P

= 0.0022) and perineural

invasion (

P

= 0.0003). Low-volume surgeon who operated fewer

than 20 cases was the only independent predictor for poor DSS

(

P

= 0.0001).

Conclusion:

Overall, the outcomes of oral SCC are better com-

pared to previous studies. The findings support the rationalisation

of oral SCC management at high-volume centres and in the hands

of experienced surgeons for better patient outcomes.

Reference

Ellis, O. G., David, M. C., Park, D. J., & Batstone, M. D. (2016). High-

volume surgeons deliver larger surgical margins in oral cavity cancer.

J

Oral Maxillofac Surg

,

74

, 1466–1472.

http://dx.doi.org/10.1016/j.ijom.2017.02.446

Dysregulation of p63/miR-138 predicts poor prognosis in

oral cancer

X.Q. Liu

∗

, Z. Zhuang, J. Hu, P. Yu, N. Xie, C. Wang, J.S. Hou,

H.Z. Huang

Department of Oral Maxillofacial-Head and Neck Oncology, the

Affiliated Hospital of Stomatology, Guanghua School of

Stomatology, Sun Yat-sen University, Guangzhou, China

Background:

p63 is critical for the development of stratified

epithelial tissues. The role of p63 in tumourigenesis remains

poorly defined.

Objectives:

We aim to determine p63 and miR-138 expression in

oral cancers (OCs), and analyse their correlation with the clinico-

pathological parameters and prognosis in patients with OCs.

Methods:

Levels of p63 and miR-138 in OCs and noncancerous

adjacent tissues (NATs) were investigated by immunohistochem-

istry and

in situ

hybridisation, respectively. The correlations of p63

and miR-138 expression with the clinicopathological parameters

and prognosis of patients with OC were analysed. p63 and miR-

138 expression in OC cell lines was measured by immunoblot or

quantitative reverse transcriptase-polymerase chain reaction. The

effects of p63 on cell migration were evaluated by knock-in or

knock-down.

Results:

Elevated p63 and reduced miR-138 were detected in

OC tissues compared with NATs (

P

< 0.05). A negative corre-

lation between p63 and miR-138 expression can be observed in

the OC tissues. We revealed that p63 and miR-138 expression

are associated with cell differentiation, lymph metastasis status

and clinical stages in patients with OCs. Cox regression analysis

showed p63 overexpression was correlated with reduced over-

all survival. Moreover, a negative correlation between p63 and

miR-138 expression was also found in OC cell lines (

P

< 0.05).

Upregulation of p63 resulted in reduced miR-138 expression

and increased cell invasion. On the contrary, knockdown of p63

enhanced miR-138 and suppressed cell migration.

Conclusion:

The dysregulation of p63 and miR-138 are com-

mon molecular events in OC progression. These findings suggest

that p63 and miR-138 may collaboratively play a role in oral

carcinogenesis.

http://dx.doi.org/10.1016/j.ijom.2017.02.447

Proposing a novel classification and staging system of

mandible osteoradionecrosis: Chinese experience

Z.L. Liu

∗

, Z.Y. Zhang, W.L. Qiu, Y. He

Shanghai Ninth People’s Hospital Affiliated to Shanghai Jiao

Tong University School of Medicine, Shanghai, China

Background:

Osteoradionecrosis (ORN) of the jaw is a common

radiation-induced complication. Several classifications and stag-

ing systems have been proposed for ORN, however, none has been

universally accepted because of their individual deficiencies.

Objectives:

The aim of this study was to introduce a new clinical

classification that can be applied to the treatment of ORN in an

easier and more acceptable way.

Methods:

A review was conducted of 99 ORN patients in our

institution between 2000 and 2013. A novel classification was

established on the basis of bone necrosis (with a cut point of 2 cm

in radiographic image, or pathological fracture) and soft tissue

defects (mucosa defect or skin fistula). A new staging system with

four different stages (stage 0, stage I, stage II, and stage III) was

proposed.

Findings:

A total of 99 patients with ORN were ultimately ana-

lysed. Radiographic analysis showed that no distinct change in

8 patients, the maximal diameter of necrotic bone >2 cm in 65

patients and that <2 cm in 14 patients, the residual 12 patients were

found with pathological fracture. Finally, 8 patients were defined

as Stage 0, 14 were classified as Stage I, 65 were categorised as

Stage II, and 12 were diagnosed as Stage III. Each stage presents

the different severity of ORN and provides suitable therapeutic

and reconstructive methods.